Literature DB >> 348288

Grain dust and the lungs.

M Chan-Yeung, M J Ashley, S Grzybowski.   

Abstract

Grain dust is composed of a large number of materials, including various types of grain and their disintegration products, silica, fungi, insects and mites. The clinical syndromes described in relation to exposure to grain dust are chronic bronchitis, grain dust asthma, extrinsic allergic alveolitis, grain fever and silo-filler's lung. Rhinitis and conjunctivitis are also common in grain workers. While the concentration and the quality of dust influence the frequency and the type of clinical syndrome in grain workers, host factors are also important. Of the latter, smoking is the most important factor influencing the frequency of chronic bronchitis. The role of atopy and of bronchial hyperreactivity in grain dust asthma has yet to be assessed. Several well designed studies are currently being carried out in North America not only to delineate the frequency of the respiratory abnormalities, the pathogenetic mechanisms and the host factors, but also to establish a meaningful threshold limit concentration for grain dust.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 348288      PMCID: PMC1818652     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  12 in total

1.  EXPOSURE TO GRAIN DUST. I. A SURVEY OF THE EFFECTS.

Authors:  N WILLIAMS; A SKOULAS; J E MERRIMAN
Journal:  J Occup Med       Date:  1964-08

2.  The role of bacterial endotoxins in occupational diseases caused by inhaling vegetable dusts.

Authors:  B PERNIS; E C VIGLIANI; C CAVAGNA; M FINULLI
Journal:  Br J Ind Med       Date:  1961-04

3.  Silo-filler's disease; a syndrome caused by nitrogen dioxide.

Authors:  T LOWRY; L M SCHUMAN
Journal:  J Am Med Assoc       Date:  1956-09-15

4.  Recurrent nocturnal asthma after exposure to grain dust.

Authors:  R J Davies; M Green; N M Schofield
Journal:  Am Rev Respir Dis       Date:  1976-11

5.  Immunologic events in pigeon breeders' disease.

Authors:  V L Moore; J N Fink; J J Barboriak; L L Ruff; D P Schlueter
Journal:  J Allergy Clin Immunol       Date:  1974-06       Impact factor: 10.793

6.  A clinical and physiologic study of grain handlers.

Authors:  M Kleinfeld; J Messite; R E Swencicki; J Shapiro
Journal:  Arch Environ Health       Date:  1968-03

7.  Hypersensitivity reactions to grain dust.

Authors:  P Warren; R M Cherniack; K S Tse
Journal:  J Allergy Clin Immunol       Date:  1974-03       Impact factor: 10.793

8.  Bronchial reactivity in occupational asthma.

Authors:  M C Pain; H S Symons
Journal:  Med J Aust       Date:  1972-03-11       Impact factor: 7.738

9.  Farmer's lung.

Authors:  W P Warren; M A Mandl; B Rose
Journal:  Can Med Assoc J       Date:  1969-04-19       Impact factor: 8.262

10.  Respiratory abnormalities among grain handlers: a clinical, physiologic, and immunologic study.

Authors:  G A DoPico; W Reddan; D Flaherty; A Tsiatis; M E Peters; P Rao; J Rankin
Journal:  Am Rev Respir Dis       Date:  1977-06
View more
  6 in total

Review 1.  Occupational asthma.

Authors:  M Chan-Yeung
Journal:  Clin Rev Allergy       Date:  1986-08

Review 2.  Grain dust and respiratory health.

Authors:  M Chan-Yeung; D Enarson; S Grzybowski
Journal:  CMAJ       Date:  1985-11-15       Impact factor: 8.262

3.  Respiratory cancer in Danish bakers: a 10 year cohort study.

Authors:  F Tüchsen; L Nordholm
Journal:  Br J Ind Med       Date:  1986-08

4.  Respiratory symptoms in Manitoba farmers: association with grain and hay handling.

Authors:  C P Warren; J Manfreda
Journal:  Can Med Assoc J       Date:  1980-06-07       Impact factor: 8.262

5.  Composition of extracts of airborne grain dusts: lectins and lymphocyte mitogens.

Authors:  S A Olenchock; D M Lewis; J C Mull
Journal:  Environ Health Perspect       Date:  1986-04       Impact factor: 9.031

6.  Pesticide Use and Asthma in Alberta Grain Farmers.

Authors:  Nicola Cherry; Jeremy Beach; Ambikaipakan Senthilselvan; Igor Burstyn
Journal:  Int J Environ Res Public Health       Date:  2018-03-15       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.